Uprima Side Effects
Generic Name: apomorphine
Note: This page contains side effects data for the generic drug apomorphine. It is possible that some of the dosage forms included below may not apply to the brand name Uprima.
It is possible that some side effects of Uprima may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
For the Consumer
Applies to apomorphine: subcutaneous solution
As well as its needed effects, apomorphine (the active ingredient contained in Uprima) may cause unwanted side effects that require medical attention.
If any of the following side effects occur while taking apomorphine, check with your doctor immediately:More common
- Chest pain, discomfort, or pressure
- cold sweats
- dizziness, faintness, or light-headedness when getting up from lying or sitting position
- falling asleep during activity
- mood or mental changes
- seeing, hearing, or feeling things that are not there
- twitching, twisting, uncontrolled repetitive movements of tongue, lips, face, arms, or legs
- Arm, back, neck or jaw pain or discomfort
- chest tightness or heaviness
- fast or irregular heartbeat
- low blood pressure or pulse
- shortness of breath
- Irregular heartbeat
- recurrent fainting
Some apomorphine side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:More common
- Bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at injection site
- blurred vision
- runny nose
- Painful or prolonged erection of the penis
For Healthcare Professionals
Applies to apomorphine: compounding powder, subcutaneous solution
Gastrointestinal side effects have included severe nausea (31%) and vomiting (11%) at the recommended doses of apomorphine (the active ingredient contained in Uprima)
In clinical trials conducted in the USA, patients were treated with trimethobenzamide for 3 days prior to initiation of treatment with apomorphine, and were directed to continue it for at least 6 weeks. The number of patients stopping apomorphine treatment due to nausea was 3% and due to vomiting was 2%.
Cardiovascular side effects have included syncope (2%). QT and QTc prolongation have been reported in very rare cases. Apomorphine (the active ingredient contained in Uprima) may cause dose-related decreases in systolic and diastolic blood pressure. Severe orthostatic hypotension, hypotension and/or syncope that resulted in drug withdrawal have been reported in less than 1% of patients in clinical trials.
Psychiatric side effects have included hallucinations (14%), confusion, paranoid ideation, delusions, disorientation, aggressive behavior, agitation, and delirium. Slowing down of cognitive performance has been reported after apomorphine (the active ingredient contained in Uprima) use in a small number of patients with Parkinson's disease. The mechanism of action is not fully understood.
Other side effects have included falling asleep during activities of daily living. There have been reports in the literature of patients suddenly falling asleep without prior warning, soon after receiving apomorphine (the active ingredient contained in Uprima) subcutaneous injections.
Local side effects have included reactions at the injection site, such as bruising (16%), granuloma (4%), and pruritus (2%).
Drug abuse and dependence have been reported rarely by patients with Parkinson's disease. These cases are characterized by frequent dosing leading to hallucinations, dyskinesia, and abnormal behavior.
Nervous system side effects have included symptoms resembling neuroleptic malignant syndrome associated with the rapid dose reduction, withdrawal of, or changes in antiparkinsonian therapy. Migraine attacks have been reported to occur following injection of apomorphine (the active ingredient contained in Uprima) in two postmenopausal women who had experienced migraines before menopause several years earlier.
Genitourinary side effects have included priapism in some patients.
Drug tolerance to apomorphine (the active ingredient contained in Uprima) after long periods of drug treatment has been observed in some studies. The decline in dopaminergic responsiveness was most noticeable with drug administrations set at 2-hour intervals.
More about Uprima (apomorphine)
- Other brands: Apokyn
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.